Precision Pain Relief through Pharmacogenomics

Course overview

0202-9999-26-241-L01-P This presentation will explore how genetic variations influence individual responses to opioid analgesics. Delving into the science of pharmacogenomics, it will highlight how genes affect opioid metabolism, efficacy, and risk of adverse effects. The session will cover key genetic markers, such as CYP2D6 and OPRM1, and their role in crafting personalized treatment plans and understanding response to therapy. Attendees will learn about current research, clinical applications, and challenges in implementing pharmacogenomic testing in pain mana